Continuous dopamine-receptor stimulation in early Parkinson's disease
- 1 October 2000
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 23, S117-S126
- https://doi.org/10.1016/s1471-1931(00)00030-6
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- De novo administration of ropinirole and bromocriptine induces less dyskinesia than L‐dopa in the MPTP‐treated marmosetMovement Disorders, 1998
- Early Treatment of Parkinson??s Disease with Cabergoline Delays the Onset of Motor ComplicationsDrugs, 1998
- A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- The Metabolic Topography of ParkinsonismJournal of Cerebral Blood Flow & Metabolism, 1994
- A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's diseaseMovement Disorders, 1994
- Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeysExperimental Neurology, 1992
- A 2-DEOXYGLUCOSE STUDY OF THE EFFECTS OF DOPAMINE AGONISTS ON THE PARKINSONIAN PRIMATE BRAINBrain, 1992
- The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neuronesTrends in Neurosciences, 1990
- Continuous and intermittent levodopa differentially affect basal ganglia functionAnnals of Neurology, 1989
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989